Articles by Michelle Hoffman - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Michelle Hoffman

It's in the Genes

In an age of "pre-existing conditions," can a new bill help patients get the treatment they need?
Sep 2, 2007

In an age of "pre-existing conditions," can a new bill help patients get the treatment they need?

Court Dissolves Schering-Plough Consent Decree

Aug 9, 2007

Schering-Plough announced today that a consent decree filed against the company in May, 2002, had been dissolved by the US District Court for the District of New Jersey in Newark.

A Moral Decision, A Vital Consequence

By vetoing stem cell research funding, the President is vetoing potentially life-saving treatments.
Aug 2, 2007

By vetoing stem cell research funding, the President is vetoing potentially life-saving treatments.

From Boon to Bubble?

Infrastructure must be in place before jumping into outsourcing.
Aug 1, 2007

Infrastructure must be in place before jumping into outsourcing.

New FDA Guidance on Polymorphic Compounds in Generic Drugs

Jul 12, 2007

A new guidance issued by the US Food and Drug Administration earlier this month advises companies on how to treat polymorphic drug compounds?those that exhibit multiple structural forms?in filing abbreviated new drug applications.

Survey Says Two Million US Adults Import Drugs without Prescriptions

Jul 5, 2007

More than five million US adults import prescription drugs from other countries, according to a survey conducted by the Pharmaceutical Research and Manufacturers of America.

Standing the Test of Time

Thirty years ago, the world was a very different place; so was the pharma industry.
Jul 2, 2007

Thirty years ago, the world was a very different place; so was the pharma industry.

Balancing Act

Perhaps Congress can help FDA meet its multiple oversight demands.
Jun 2, 2007

Perhaps Congress can help FDA meet its multiple oversight demands.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
13%
To select process for new products only
26%
To select processes for both new and legacy products
21%
Do not use QbD
21%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Click here